AZD5305
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for AZD5305, covering 2024-06-18 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: AZD5305 hADME in Patients With Advanced Solid Malignancies [Phase 1]